Abivax Completes Recruitment of ABX464 Phase IIa HIV Study
Go back to Abivax Completes Recruitment of ABX464 Phase IIa HIV Study| (NASDAQ: ABVX) | Delayed: 92.51 -5.92 (6.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.43 | 52 Week High | $ | |||
| Open | $97.94 | 52 Week Low | $ | |||
| Day High | $98.46 | P/E | N/A | |||
| Day Low | $74.79 | EPS | $ | |||
| Volume | 6,728,611 | |||||
